Lakefront Biotherapeutics | GLPG - Ativos





Ativos Alterar Data
argenx SE USD 10.03B 1.35B 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
Biogen USD 32.05B 32.5M 2026-09
Genmab DKK 12.52B 139M 2026-06
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
GRIFOLS EUR 20.28B 191M 2026-09
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Incyte USD 7.29B 585.39M 2026-09
Merck EUR 52.69B 383M 2026-06
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
UCB EUR 18.16B 971M 2025-12
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09